Cargando…
Outpatient medications associated with protection from COVID-19 hospitalization
The COVID-19 pandemic remains the pre-eminent global health problem, and yet after more than three years there is still no prophylactic agent against the disease aside from vaccines. The objective of this study was to evaluate whether pre-existing, outpatient medications approved by the US Food and...
Autores principales: | Sandhu, Harpal Singh, Lambert, Joshua, Steckler, Zach, Park, Lee, Stromberg, Arnold, Ramirez, Julio, Yang, Chi-fu Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065249/ https://www.ncbi.nlm.nih.gov/pubmed/37000808 http://dx.doi.org/10.1371/journal.pone.0282961 |
Ejemplares similares
-
A strategy to identify event specific hospitalizations in large health claims databases
por: Lambert, Joshua, et al.
Publicado: (2022) -
Systemic immunosuppression and risk of age-related macular degeneration
por: Sandhu, Harpal S., et al.
Publicado: (2018) -
p-Value Histograms: Inference and Diagnostics
por: Breheny, Patrick, et al.
Publicado: (2018) -
COVID-19 Protection Guidelines in Outpatient Medical Imaging Centers
por: Sedaghat, Abdolrasul, et al.
Publicado: (2020) -
Alterations in Hematological Profile of Experimentally Induced Subchronic Thiacloprid Toxicosis in Gallus domesticus
por: Singla, Saloni, et al.
Publicado: (2015)